The sword of Damocles. Managing fear of cancer recurrence with the SWORD intervention study (Survivors' Worries of Recurrent Disease).

The sword of Damocles. Managing fear of cancer recurrence with the SWORD intervention study (Survivors' Worries of Recurrent Disease). - SWORD study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON39571

Enrollment

104

Registered

2013-07-02

Start date

2014-02-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer colorectal cancer prostate cancer

Interventions

The intervention will be developed by researchers and psychologists of the department of Medical Psychology (UMC st. Radboud). Psychologists of this department are specialized in treating cancer pat

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Breast, colorectal and prostate cancer survivors up to 5 years after finishing primary treatment - At the moment of the study disease-free, as defined by the absence of somatic disease activity parameters. - Age of 18 and older. - Cancer Worry Scale score of 14 or higher, indicating a high level of fear of cancer recurrence - Sufficient understanding of the Dutch language to fill out questionnaires - Able to travel to hospital for CBT intervention

Exclusion criteria

Exclusion criteria: - Primary treatment completed less than 6 months ago. - Currently in active (psychological/psychiatric) treatment for psychiatric comorbidity.

Design outcomes

Secondary

Measure	Time frame
1. Disease specific quality of life (QLQ-C30), supplemented by a disease specific module: BR23 for breast cancer, CR29 for colon cancer or PR25 for prostate cancer. . 2. Satisfaction with (Quality of) Life (Satisfaction With Life Scale) 3. Cost-effectiveness and health-status (EQ-5D and patient diaries). Other: Mediators and moderators: Body Vigilance (Body Vigilance Scale), aspects of fear of cancer recurrence (Fear of Cancer Recurrence Inventory) emotional wellbeing (Hospital Anxiety and Depression Scale). Personality factors (The Big Five Inventory) Optimism (Life Oriëntation Test), Social Support (Sociale Steun Lijst- Discrepanties), fatigue (Verkorte Vermoeidheids Vragenlijst - 8) and impact of events (Schokverwerkingslijst). For both patient groups, also medical disease-specific data are collected.	—

Measure

Time frame

1. Disease specific quality of life (QLQ-C30), supplemented by a disease specific module: BR23 for breast cancer, CR29 for colon cancer or PR25 for prostate cancer. . 2. Satisfaction with (Quality of) Life (Satisfaction With Life Scale) 3. Cost-effectiveness and health-status (EQ-5D and patient diaries). Other: Mediators and moderators: Body Vigilance (Body Vigilance Scale), aspects of fear of cancer recurrence (Fear of Cancer Recurrence Inventory) emotional wellbeing (Hospital Anxiety and Depression Scale). Personality factors (The Big Five Inventory) Optimism (Life Oriëntation Test), Social Support (Sociale Steun Lijst- Discrepanties), fatigue (Verkorte Vermoeidheids Vragenlijst - 8) and impact of events (Schokverwerkingslijst). For both patient groups, also medical disease-specific data are collected.

—

Primary

Measure	Time frame
Severity of fear of cancer recurrence (measured with the Cancer Worry Scale).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)